Prelude Capital Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Prelude Capital Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell
2025 Q3	$646K	Sell
2025 Q2	$658K	Buy
2025 Q1	$515K	Hold
2024 Q4	$600K	Sell
2024 Q3	$590K	Sell
2024 Q2	$622K	Sell
2024 Q1	$781K	Buy
2022 Q2	–	Sell
2022 Q1	$102K	Buy